Dr. Moria Gunn speaks with Jay Siegel and Garry Neil, Chief Biotechnology Officer and Corporate VP for Science and Technology with Johnson and Johnson, about their biotechnology strategy and their worldwide search for disruptive technologies.
Dr. Moira Gunn discusses the manufacturing of heart cells with Cellular Dynamics International CEO, Bob Palay and then switches gears, talking with Dr. Mark Goldberg, Chairman of PlantForm Corporation, where they are using the tobacco plant in drug manufacturing.
Dr. Moira Gunn talks with Mark Ledwidge and John Gilmer, from Solvotrin Therapeutics, about how they're finding new uses for Aspirin.
Dr. Moira Gunn talks with Elan Pharmaceuticals President, Carlos Paya about the latest in innovative approaches to treating Alzheimer's and Parkinson's patients.
Dr. Moira Gunn catches up with author and columnist, David Duncan, to hear about the US Judge who has ruled against President Obama's stem cell policy.
Dr. Moria Gunn chats with the CEO for Somnus Therapeutics, Gary Cupit, on a new use for an old drug which is helping the weary sleep better.
Dr. Moira Gunn talks with Biotech columnist and author, David Ewing Duncan, about the attention genetic testing is receiving from the FDA, the National Institutes of Health *and* the Government Accounting Office.
Dr. Moira Gunn talks with the Director of Community for Harvard Medical School, Jason Bobe, about the Personal Genomes Project and "Do It Yourself" Biotech.
Dr. Moria Gunn talks with columnist and author David Ewing Duncan about what happens and who suffers when a prestigious journal publishes flawed science.
Dr. Moira Gunn talks about CO2 with President and CEO, Glenn Kelly,how the human body manages CO2, and how his cleantech company, CO2 Solutions, copies it.